Skip Navigation

Text From Here.

Clinical Research into Pancreatic Surgery

  While pancreatic resection has become safer than it used to be, it is still a procedure accompanied by risk of mortality from complications. We are engaged in proactive clinical research with the aim of developing surgical methods that will allow us to solve outstanding scientific problems, while being safer and kinder to the body. In addition, pancreatic cancer is a typically refractory malignant form of cancer. We are engaged in clinical research in order to improve treatment results. We ask for your understanding in terms of our treatment results and clinical testing.

Prospective Clinical Trials to Date

  1. Pylorus preserving pancreatoduodenectomy reconstruction methods: RCT (colon anterior reconstruction vs. colon posterior reconstruction)
  2. Reduction of infection-related complications by early removal of drain
  3. Use of 3D-CT to identify arteries and prevent blood loss through early ligation
  4. Relationship between pancreatic duct tube and post-surgical complications: RCT
  5. The significance of the pylorus in subtotal stomach-preserving pancreaticoduodenectomy: RCT
  6. Phase I clinical trial (physician-led) into combined use of Gemcitabine and VGEFR-2 peptide

Prospective Trials Currently Underway

  1. Reconstructive surgical techniques in pancreaticoduodenectomy: RC
  2. Phase II/III clinical trial PEGASUS study  into inoperable recurring advanced pancreatic cancer
  3. Phase II clinical trial into inoperable recurring biliary duct cancer
  4. Effectiveness of reducing side-effects of Fentanyl patch use in relation to cancer-related algia
  5. SSI liver/pancreas trials (multicenter joint parallel-group randomized comparative trial into the effects of controlling infection in surgical areas by using synthetic absorbent sutures in liver resection and pancreaticoduodenectomy): RCT

Basic Research

  1. Basic analysis of peptide vaccine treatment in regard to pancreatic cancer
  2. Comprehensive genetic analysis of pancreatic cancer
  3. Cellular malignant alteration in epithelial-mesenchymal transition in pancreatic cancer cases
  4. The relationship between glycoproteins and pancreatic cancer infiltration
  5. Predictive factors for cancerous alteration of intraductal papillary mucinous tumors